Injectable acrylic bone cements for vertebroplasty based on a radiopaque hydroxyapatite. Bioactivity and biocompatibility

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 88, Issue 1, 2009, Pages 103-114

  Hernández, Lidia ^a   Parra, Juan ^b   Vázquez, Blanca ^c   Bravo, Antonio López ^b   Collía, Francisco ^d   Goñi, Isabel ^a   Gurruchaga, Marilo ^a   San Román, Julio San ^c  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c CSIC   (Spain)

^d UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Bioactive material; Biocompatibility; PMMA bone cement; Radiopacity; Strontium hydroxyapatite

Indexed keywords

ACRYLIC BONE CEMENTS; AFTER TREATMENTS; BIOACTIVE COMPOUNDS; BIOACTIVE MATERIAL; CELLULAR PROLIFERATIONS; CEMENT PASTES; COLLAGEN FIBERS; FTIR SPECTROSCOPIES; GIANT CELLS; IN VITRO BIOACTIVITIES; IN-VIVO; INFLAMMATORY CELLS; KYPHOPLASTY; PMMA BONE CEMENT; RADIOPACITY; SIMULATED BODY FLUID SOLUTIONS; STRONTIUM HYDROXYAPATITE; VERTEBROPLASTY;

ALKALINE EARTH METALS; APATITE; BIOCERAMICS; BIOCOMPATIBILITY; BONE; CELL CULTURE; CELL MEMBRANES; CELL PROLIFERATION; CEMENTS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HYDROXYAPATITE; MONOMERS; PHOSPHATE MINERALS; STRONTIUM;

BONE CEMENT;

ACRYLIC CEMENT; APATITE; BONE CEMENT; COLLAGEN FIBER; HYDROXYAPATITE; STRONTIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CELL PROLIFERATION; DRUG ACTIVITY; FIBROBLAST; GIANT CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; INFRARED SPECTROSCOPY; KYPHOPLASTY; LYMPHOCYTE; MACROPHAGE; NONHUMAN; PERCUTANEOUS VERTEBROPLASTY; PRECIPITATION; RAT; TREATMENT OUTCOME;

ANIMALS; APATITES; BIOCOMPATIBLE MATERIALS; BONE CEMENTS; CELL PROLIFERATION; COLLAGEN; DURAPATITE; FEMALE; GIANT CELLS; LYMPHOCYTES; POLYMETHYL METHACRYLATE; RATS; RATS, WISTAR; VERTEBROPLASTY;

EID: 57349098177     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31156     Document Type: Article

References (38)

1. Amoretti N, Hovorka E, Marcy P, Lamasse C, Brunner P, Roux C, Chevallier P, Boileau P, Bruneton J. Burst fracture of the spine involving vertebrae presenting no other lesions: The role of vertebroplasty. Clin Imag 2005;29:379-382.
2. Suresh SP, Whitehouse RW. Vertebroplasty and kyphoplasty. J Brit Men Soc 2005;11:28-32.
3. Deramond H, Depriester C, Galibert P, Le Gars D. Percutaneous vertebroplasty with polymethylmethacrylate. Technique, indications, and results. Radiol Clin North Am 1998;36:533-546.
4. Truumees E, Hilibrand A, Vaccaro AR. Percutaneous vertebral augmentation. Spine J 2004;4:218-229.
5. Heini PF, Berlemann U. Bone substitutes in vertebroplasty. Eur Spine J 2001;10:S205-S213.
6. Lewis G. Injectable bone cements for use in vertebroplasty and kyphoplasty: State-of-the-art review. J Biomed Mat Res B Appl Biomater 2006;76:456-468.
7. Jasper LE, Deramond H, Mathis JM, Belkoff SM. Material properties of various cements for use with vertebroplasty. J Mater Sci: Mater Med 2002;13:1-5.
8. Frankenburger EP, Goldstein SA, Bauer TW, Harris SA, Poser RD. Biomechanical and histological evaluation of a calcium phosphate cement. J Bone Joint Surg A 1998;80:1112-1124.
9. Ikenaga M, Hardouin P, Lemaitre J, Andrianjatovo H, Flautre B. Biomechanical characterization of a biodegradable calcium phosphate hydraulic cement: A comparison with porous biphasic calcium phosphate ceramics. J Biomed Mater Res 1998;40:139-144.
10. Heini PF, Wälchli B, Berlemann U. Percutaneous transpedicular vertebroplasty with PMMA: Operative technique and early results. A prospective study for the treatment of osteoporotic compression fractures. Eur Spine J 2000;9:445-450.
11. Jensen ME, Evans AJ, Mathis JM, Kallmes DF, Cloft HJ, Dion JE. Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: Technical aspects. Am J Neuroradiol 1997;18:1897-1904.
12. Wilkes RA, Mackinnon JG, Thomas WG. Neurological deterioration after cement injection into a vertebral body. J Bone Joint Surg Br B 1994;76:155.
13. Weill A, Chiras J, Simon J. Spinal metastases: Indications for and results of percutaneous injection of acrylic surgical cement. Radiology 1996;199:241-247.
14. Dalby MJ, Di Silvio L, Harper EJ, Bonfield W. Increasing hydroxyapatite incorporation into poly(methylmethacrylate) cement increases osteoblast adhesion and response. Biomaterials 2002;23:569-576.
15. Miyaji F, Morita Y, Kokubo T, Nakamura T. Surface structural change of bioactive inorganic filler-resin composite cement in simulated body fluid: Effect of resin. J Biomed Mater Res 1998;42:604-610.
16. Heikkilä JT, Aho AJ, Kangasniemi I, Yli-Urpo A. Polymethylmethacrylate composites disturbed bone formation at the surface of bioactive glass and hydroxyapatite. Biomaterials 1996;17:1755-1760.
17. Mousa WF, Kobayashi M, Kitamura Y, Zeineldin IA, Nakamura T. Effect of silane treatment and different resin compositions on biological properties of bioactive bone cement containing apatite-wollastonite glass ceramic powder. J Biomed Mater Res 1999;47:336-344.
18. González Corchón MA, Salvado M, de la Torre B, Collía F, de Pedro JA, Vázquez B, San Román J. Injectable and selfcuring composites of acrylic/bioactive glass and drug systems. A histomorphometric analysis of the behaviour in rabbits. Biomaterials 2006;27:1778-1787.
19. Li YW, Leong JCY, Lu WW, Luk KDK, Cheung KMC, Chiu KY, Chow SP. A novel injectable bioactive bone cement for spinal surgery: A developmental and preclinical study. J Biomed Mater Res 2000;52:164-170.
20. Ni GX, Chiu KY, Lu WW, Wang Y, Zhang YG, Hao LB, Li ZY, Lam WM, Lu SB, Luk KDK. Strontium-containing hydroxyapatite bioactive bone cement in revision hip arthroplasty. Biomaterials 2006;27:4348-4355.
21. Hernández L, Goñi I, Gurruchaga M. Injectable acrylic bone cements for vertebroplasty based on a radiopaque hydroxyapatite. J Biomed Mater Res B. Forthcoming.
22. Kokubo T, Kim H-M, Kawashita M. Novel bioactive materials with different mechanical properties. Biomaterials 2003;24:2161-2175.
23. Hernández L, Gurruchaga M, Goñi I. Influence of powder particle size distribution on complex viscosity and other properties of acrylic bone cement for vertebro plasty and kyphoplasty. J Biomed Mater Res B 2006;77: 98-103.
24. Zhao F, Lu WW, Luk KDK, Cheung KMC, Wong CT, Leong JCY, Yao KD. Surface treatment of injectable strontium-containing bioactive bone cement for vertebroplasty. J Biomed Mater Res B Appl Biomater 2004;69:79-86.
25. Mosmann T. Rapid colorimetric assay of cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
26. Wan H, Williams R, Doherty P, Williams DF. A study of the reproducibility of the MTT test. J Mater Sci: Mater Med 1994;5:154-159.
27. Clifford CJ, Downes S. A comparative study of the use of colorimetric assays in the assessment of biocompatibility. J Mater Sci: Mater Med 1996;7:637-643.
28. Nociari MM, Shalaev A, Benias P, Russo C. A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity in vitro. J Immunol Methods 1998;213:157-167.
29. Decker T, Lohmann-Matthes ML. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 1988;15:61-69.
30. Legrand C, Bour JM, Jacob C, Capiaumont J, Martial A, Marc A, Wudtke M, Kretzmer G, Demangel C, Duval D, Hache J. Lactate dehydrogenase (LDH) activity of the number of dead cells in the medium of cultured eukaryotic cells as marker. J Biotechnol 1992;25:231-243.
31. ISO 10993-6. Biological evaluation of medical devices. Part 6: Tests for local effects after implantation; 1994.
32. Chen QZ, Wong CT, Lu WW, Cheung KMC, Leong JCY, Luk KDK. Strengthening mechanisms of bone bonding to crystalline hydroxyapatite in vivo. Biomaterials 2004;25:4243-4254.
33. Deb S, Aiyathurai L, Roether JA, Luklinska ZB. Development of high-viscosity, two-paste bioactive bone cements. Biomaterials 2005;26:3713-3718.
34. Méndez JA, Fernández M, González-Corchón A, Salvado M, Collía F, de Pedro JA, Levenfeld BL, López-Bravo A, Vázquez B, San Román J. Injectable self-curing bioactive acrylicglass composites charged with specific anti-inflammatory/analgesic agent. Biomaterials 2004;25:2381-2392.
35. Miyazaki T, Ohtsuki C, Kyomoto M, Tanihara M, Mori A, Kuramoto K. Bioactive PMMA bone cement prepared by modification with methacryloxypropyltrimethoxy silane and calcium chloride. J Biomed Mater Res A 2003;67:1417-1423.
36. Ni GX, Lu WW, Chiu KY, Li ZY, Fong DYT, Luk KDK. Strontium-containing hydroxyapatite (Sr-HA) bioactive cement for primary hip replacement: An in vivo study. J Biomed Mater Res B 2006;77:409-415.
37. Dillingham EO, Web N, Lawrence WH, Autian J. Biological evaluation of polymers. I. Poly(methyl methacrylate). J Long-Term Effects Chem Implants 2005;15:629-639.
38. Lidgren L, Robertson O. Acrylic bone cements: Clinical developments and current status: Scandinavia. Orthop Clin North Am 2005;36:55-61.